OT: Stock and Investment Talk
- Thread starter RU-05
- Start date
I don’t think it’s bad results that caused the dropped.
I think it’s because the National Institute of Health (NIH) may own intellectual property of the vaccine.
" Downbeat results from tests of a cancer vaccine based on an unproven technology cast doubt over the chances of using that approach to develop coronavirus vaccines, says HSBC. The bank says data from trials of BNT-122, which uses mRNA technology and was developed by BioNTech and partner Roche Holding, showed what HSBC described as 'clearly disappointing' patient responses. HSBC says the results suggest mRNA-based vaccines may not be as immunogenic as hoped. BioNTech and partner Pfizer, as well as Moderna Inc., are developing Covid-19 vaccines based on mRNA approaches. "The failure of BNT-122 should provide pause for thought on the prospects for mRNA approaches in vaccination for COVID-19 and other diseases," HSBC analyst Steve McGarry says. (philip.waller@wsj.com)"
What are peoples thought on IDA?
It's chart is a consistent upward trend since 2009. It shows a profit. It pays a dividend.
It was at $115 precovid, currently at $86. Went as low as $77. Has recently met resistance twice at around $96.
Looks to be a pretty green energy producer as well. Edit: In part, some coal in there as well.
It's chart is a consistent upward trend since 2009. It shows a profit. It pays a dividend.
It was at $115 precovid, currently at $86. Went as low as $77. Has recently met resistance twice at around $96.
Looks to be a pretty green energy producer as well. Edit: In part, some coal in there as well.
I bought Innovio Pharm at $8.00. Today it is at 24.00. 300% return.
For me, hard pass. Utilities are doing terribly right now. But they are profitable and pay a decent dividend.
OTOH Idaho has had a strong economy. A lot of folks were moving to Boise for a nice quality of life.
Just looked at their chart. I don't see it above 15 recently. But if you made 300% - booh-yah!
But don't you get a value aspect on a company that is not getting squeezed the way retail or airlines are? Not sure but is the pandemic actually hurting their business?
The stock market is hard to figure out in the best of times. Personally, I absorbed all the pain I could handle in the utility sector about a month ago. What really cheesed me was SPLV (S&P 500 low vol-utility heavy fund) was a giant turd in the punch bowl since the pandemic started. I know the playbook says to go defensive during a downturn, but that strategy just hasn't worked this time. Here's an article from Schwab that I think is pretty good:
For one thing, because some investors had already been reaching for yield before the crisis began, the high-dividend-paying Utilities sector had been bid up to record-high valuation levels. Even underperformance year-to-date hasn’t fully reversed those relatively high valuations, so we're not confident the sector will return to its defensive roots if markets sell off again.
Additionally, with improving prospects for economic growth, longer-term yields have begun to nudge higher, which further reduces the sector's attractiveness. The fundamentals of the sector remain relatively strong, owing to still-low interest rates supporting capital expenditure needs and stability of earnings growth expectations. However, the sector's short-term relative performance has lagged amid a turn towards more cyclical sectors. Therefore, we are underweighting Utilities, despite expected bouts of volatility in the overall market.
https://www.schwab.com/resource-center/insights/content/utilities-sector
For as much as I know AMZN is monster that will continue to steamroll in the years to come.
And I sold at $2400 thinking they were at peak, so I missed the climb to $2740. But they along with some others that are so far above precovid highs seem like they are set up for a deflation.
And I sold at $2400 thinking they were at peak, so I missed the climb to $2740. But they along with some others that are so far above precovid highs seem like they are set up for a deflation.
For me, Amazon is a stock that I plan to hold for a long, long time.
I know, I know, I keep waiting for a dip, but it keeps climbing.
Should have held it, but it was caught in a lull when the market was running around it a couple weeks ago.
Itchy trigger finger.
Living and learning.
Just heard someone reiterating what you say here. So maybe they are getting hit on two fronts?
You did the right thing. If you sell at the price you want rather than trying to be greedy you will come out ahead more often than not.
I did once. The second time I was just trying to shift to stocks that were rising at a faster rate. That was a poor trade.
But your thought does relate to a couple other trades that I made money on, then lamented as the stock rose, but then appreciated as the stock dove below my sale price. See GNUS on this one.
I see now, INO, not INVA.
Just under $30 now. A heads up around $8 would have been nice. :WideSmile:
OK, I was looking at Innoviva, not Inovio (where do they get these names).
BTW, this reminds of the time I thought I bought shares of Learjet. I actually owned Lear - an automobile seat manufacturer. Didn't realize this for a year, but stock was up well over 50% over the period. One mistake that was profitable.
I bought some southern power company thinking it was southern comfort. Tiny amount, but I did ok with it.OK, I was looking at Innoviva, not Inovio (where do they get these names).
BTW, this reminds of the time I thought I bought shares of Learjet. I actually owned Lear - an automobile seat manufacturer. Didn't realize this for a year, but stock was up well over 50% over the period. One mistake that was profitable.
My brother a former stockbroker at UBS gave me Innovio at $3.00 last year. About a month ago, 60 Minutes did a piece on Innovio. However, I would be surprised to see it at $80.00.
What did you buy at?
Funny that we we talking about it at $24earlier today and it sounded too hot to even consider.
Could have made 40ish% in a couple hours.
Utilities are good for long term invests, because they have Commissions/Boards that keep moving up rates as their costs increase.
Deregulation of State power generation is a very complex difficult and capital intensive business. For example, Nukes sell their power into the power grids at night in non=humid conditions for almost zero cost.
But when it's hot and humid you need power from somewhere to maintain life and business.
Deregulation of State power generation is a very complex difficult and capital intensive business. For example, Nukes sell their power into the power grids at night in non=humid conditions for almost zero cost.
But when it's hot and humid you need power from somewhere to maintain life and business.
Did you look at IDA ?
Do you think the consistent growth we have seen over the last 10 years is sustainable post covid?
The surface level stuff looks very good to my eye.
IDA's service area may actually see increased growth due to the pandemic.
You don't double your money in six weeks with utilities, nor would you lose 60% as long as you're not operating in California. But with the yield on 10 year bonds at .10%, it's worth looking at a 4% low tax yield as an alternative and comparing risk.
Power companies biggest costs are how do they construct NEW power generation sources, IF growth in their service area grows past their current/expected generation capabilities in their service grid.
Is there enough alternative power generation sources within the grid to supply peak needs/loads.
Their second biggest cost is employee benefits,salary, heath care, pensions.
You can move/purchase power from outside your grid, but it's usually more expensive than purchasing it within your specific power grid.
Long term IDA looks, good, because of the economic/social turmoil in Calif/Wash. So the look at IDA is to see what their power generation is capable of producing now and the transmission lines ability to deliver the power where it will be needed for the next 5-10 years. How much excess power generation do they have before they have to built/find more power for the grid ?
I was Sales Mgr for an Electric Power Co, we bought power from the grid and delivered it to mainly huge power users. Without the necessary ability to accurately forecast the power needs of your customer by THE hour, since that is how it's bought, you will go bust quickly. So places like City Water Supply, large manufacturing facilities that always use power, but it's easier to chart their needs by the hour are the best customers. Your profitability is your reduced costs of employee salary and benefits over the normal power utility.
I think that happened with zoom a few months ago. There was another company with a similar name that people were buying up and the stock was rising even though the company was barely aliveOK, I was looking at Innoviva, not Inovio (where do they get these names).
BTW, this reminds of the time I thought I bought shares of Learjet. I actually owned Lear - an automobile seat manufacturer. Didn't realize this for a year, but stock was up well over 50% over the period. One mistake that was profitable.
edit: found the story
https://securityboulevard.com/2020/04/investors-buy-up-the-wrong-zoom/
For those that follow the Covid post on the football board, I have previously advised about Cytodyn Inc. CYDY, a little small biotech firm out of Vancouver , Washington , who has a a drug called Leronlimab that will likely be the next treatment for Covid in less than a month. Yesterday it finished it’s mild/ moderate trial and on Monday , the severe/ critical trial will be able to reveal interim results. After the data is collected it will be given to the FDA in the next week to 10 days and I predict approval for Covid in July. Leronlimab initially has proved safe in over 800 patients in Phase 3 trials for AIDS and was on course to be approved as a mono therapy AIDS drug. It also is in Phase 2 trials for triple breast cancer and recently for NASH ( liver disease and fibrosis). It also might have another 10 indications for Ms,, Pancreatic and prostrate cancer, etc. it will have 10 phase 2 trials for different indications before the end of the year .
The company is presently on the OTC BUT up listing to the NYSE is happening within the next 2-3 weeks. The stock was .50 for years until end of February when it ran up to 2.50. It is presently on a 6 day surge and trading at about $7.00 as I type this as it is breaking records on stock price and volume , which was like a million , was 18.5 million yesterday , and already almost 7 million today. The anticipation from the early EIND use, which had really favorable results have ramped up in anticipation of the great trial results forthcoming . Leronlimab blocks the cytokines storm, reduces the viral load, and brings the immune system to homeostasis allowing it to fight normally , doing all 3 things. It will save lives and allow us to have a somewhat normal life. Good luck to all.
The company is presently on the OTC BUT up listing to the NYSE is happening within the next 2-3 weeks. The stock was .50 for years until end of February when it ran up to 2.50. It is presently on a 6 day surge and trading at about $7.00 as I type this as it is breaking records on stock price and volume , which was like a million , was 18.5 million yesterday , and already almost 7 million today. The anticipation from the early EIND use, which had really favorable results have ramped up in anticipation of the great trial results forthcoming . Leronlimab blocks the cytokines storm, reduces the viral load, and brings the immune system to homeostasis allowing it to fight normally , doing all 3 things. It will save lives and allow us to have a somewhat normal life. Good luck to all.
Might be a good time to start building an infrastructure portfolio. Materials, equipment, services, etc.
With the economic downturn and job loss and a pressing need to update/upgrade critical components of the nation's infrastructure, we should see bipartisan support to get going. Should be a popular topic with candidates this fall.
So look for leading players in this area and start accumulating on market drops.
Thoughts?
With the economic downturn and job loss and a pressing need to update/upgrade critical components of the nation's infrastructure, we should see bipartisan support to get going. Should be a popular topic with candidates this fall.
So look for leading players in this area and start accumulating on market drops.
Thoughts?
Similar threads
